Phenotypic and molecular characterization of a recurrent SPTAN1 mutation causing SPG91
- PMID: 40397273
- DOI: 10.1007/s11033-025-10582-4
Phenotypic and molecular characterization of a recurrent SPTAN1 mutation causing SPG91
Abstract
Background: Spectrins are ubiquitous cytoskeleton proteins found in all metazoan cells. αII-spectrin, encoded by SPTAN1, is the pivotal protein responsible for organization of the axonal cytoskeleton. Monoallelic SPTAN1 mutations cause various inherited neurological diseases, including spastic paraplegia 91 (SPG91), a type of hereditary spastic paraplegia (HSP).
Methods and results: We reported two patients with SPG91 caused by the SPTAN1 mutation c.55 C > T (p.Arg19Trp), who presented with lower limb spasticity and polyneuropathy. An analysis of the patients reported in the literature in addition to the present patients revealed that SPTAN1 p.Arg19Trp was specific for an HSP phenotype, with 35% of the combined patients with sensory‒motor polyneuropathy and 30% with cerebellar ataxia. In computational simulations, this variant was predicted to perturb the stability of αII/β spectrin heterotetramerization but did not destabilize the tetramerization domain of αII-spectrin.
Conclusions: Our findings on genotype‒phenotype correlations and genetic effects on molecular characteristics may provide important insights into the exploration of αII-spectrin-related neurological diseases.
Keywords: Hereditary spastic paraplegia; Membrane periodic skeleton; Protein‒protein interaction; SPG91; Spectrin heterotetramer; αII-spectrin.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethical approval: The study was approved by the Chang Gung Memorial Hospital Institutional Review Board (No. 100–4460 C). Written informed consent was obtained from the participants. Competing interests: The authors declare no competing interests.
References
-
- Avila J, Sousa MM, Sayas CL (2020) Editorial: shaping the brain by neuronal cytoskeleton: from development to disease and degeneration. Front Cell Neurosci 14:12. https://doi.org/10.3389/fncel.2020.00012 - DOI - PubMed - PMC
-
- Lorenzo DN, Edwards RJ, Slavutsky AL (2023) Spectrins: molecular organizers and targets of neurological disorders. Nat Rev Neurosci 24(4):195–212. https://doi.org/10.1038/s41583-022-00674-6 - DOI - PubMed - PMC
-
- Syrbe S, Harms FL, Parrini E et al (2017) Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy. Brain 140(9):2322–2336. https://doi.org/10.1093/brain/awx195 - DOI - PubMed - PMC
-
- Miazek A, Zalas M, Skrzymowska J et al (2021) Age-dependent ataxia and neurodegeneration caused by an ΑII spectrin mutation with impaired regulation of its Calpain sensitivity. Sci Rep 11(1):7312. https://doi.org/10.1038/s41598-021-86470-1 - DOI - PubMed - PMC
-
- Van de Vondel L, De Winter J, Beijer D et al (2022) De Novo and dominantly inherited SPTAN1 mutations cause spastic paraplegia and cerebellar Ataxia. Mov Disord 37(6):1175–1186. https://doi.org/10.1002/mds.28959 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
